Neptune Medical, a leader in medical device innovation, today announced the successful spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97 million Series D financing. Sonder Capital and Olympus Corporation of the Americas were significant participants in this round, along with investments from other existing and new investors.

Neptune Medical is at the forefront of developing advanced medical devices, with a primary focus on gastrointestinal robotics. The company's mission is to enhance patient outcomes through innovative technology and collaborative partnerships.